Moxibustion treatment for Parkinson’s disease: study protocol for a randomized controlled trial

BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disorder and seriously affects quality of life globally. Moxibustion is widely used to treat neurodegenerative diseases in the clinic and has achieved a beneficial clinical effect. However, strict control and high-quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chunxiao, Zhao, Lijun, Guo, Yuelin, Hao, Xiaoqian, Fan, Yaohua, Wu, Peipei, Han, Jiajun, Li, Qinglian, Wang, Xiaoling, Wang, Qizhang, Luo, Xiaodong, Zhu, Meiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258984/
https://www.ncbi.nlm.nih.gov/pubmed/37303044
http://dx.doi.org/10.1186/s12906-023-03995-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258984/
https://www.ncbi.nlm.nih.gov/pubmed/37303044
http://dx.doi.org/10.1186/s12906-023-03995-w

Ejemplares similares